136 related articles for article (PubMed ID: 2693076)
1. Efficacy of ethanolamine and polidocanol in the eradication of esophageal varices. A prospective randomized trial.
Balanzó J; Sainz S; Espinós JC; Such J; Segura J; Guarner C; Cussó X; Vilardell F
Endoscopy; 1989 Nov; 21(6):251-3. PubMed ID: 2693076
[TBL] [Abstract][Full Text] [Related]
2. Ethanolamine oleate is superior to polidocanol (aethoxysklerol) for endoscopic injection sclerotherapy of esophageal varices: a prospective randomized trial.
Kitano S; Iso Y; Koyanagi N; Higashi H; Sugimachi K
Hepatogastroenterology; 1987 Feb; 34(1):19-23. PubMed ID: 3552917
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of 5% ethanolamine oleate versus 5% ethanolamine oleate plus 1% polidocanol for sclerosing esophageal varices.
Kitano S; Wada H; Tanoue K; Hashizume M; Koyanagi N; Sugimachi K
Hepatogastroenterology; 1992 Dec; 39(6):546-8. PubMed ID: 1483669
[TBL] [Abstract][Full Text] [Related]
4. Immediate endoscopic injection therapy of bleeding oesophageal varices: a prospective comparative evaluation of injecting materials in Egyptian patients with portal hypertension.
Omar MM; Fakhry SM; Mostafa I
J Egypt Soc Parasitol; 1998 Apr; 28(1):159-68. PubMed ID: 9617052
[TBL] [Abstract][Full Text] [Related]
5. Balloon-Occluded Retrograde Transvenous Obliteration for the Treatment of Gastric Varices: Polidocanol Foam Versus Liquid Ethanolamine Oleate.
Itou C; Koizumi J; Hashimoto T; Myojin K; Kagawa T; Mine T; Imai Y
AJR Am J Roentgenol; 2015 Sep; 205(3):659-66. PubMed ID: 26295655
[TBL] [Abstract][Full Text] [Related]
6. A prospective randomized controlled trial of sclerotherapy vs ligation in the prophylactic treatment of high-risk esophageal varices.
Svoboda P; Kantorová I; Ochmann J; Kozumplík L; Marsová J
Surg Endosc; 1999 Jun; 13(6):580-4. PubMed ID: 10347295
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic sclerotherapy in a rat model of esophageal varices.
Nishida R; Inoue R; Takimoto Y; Hamashima H; Kita T
Scand J Gastroenterol; 1995 May; 30(5):489-96. PubMed ID: 7638578
[TBL] [Abstract][Full Text] [Related]
8. N-butyl-2-cyanoacrylate (Histoacryl) plus sclerotherapy versus sclerotherapy alone in the treatment of bleeding esophageal varices: a randomized prospective study.
Feretis C; Dimopoulos C; Benakis P; Kalliakmanis B; Apostolidis N
Endoscopy; 1995 Jun; 27(5):355-7. PubMed ID: 7588348
[TBL] [Abstract][Full Text] [Related]
9. A sclerosant with astringent properties developed in China for oesophageal varices: comparison with ethanolamine oleate and polidocanol.
Nishida R; Inoue R; Takimoto Y; Kita T
J Gastroenterol Hepatol; 1999 May; 14(5):481-8. PubMed ID: 10355514
[TBL] [Abstract][Full Text] [Related]
10. Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study.
Oho K; Iwao T; Sumino M; Toyonaga A; Tanikawa K
Endoscopy; 1995 Jun; 27(5):349-54. PubMed ID: 7588347
[TBL] [Abstract][Full Text] [Related]
11. Gastric bleeding after endoscopic injection sclerotherapy for esophageal varices may be fatal.
Higashi H; Kitano S; Hashizume M; Yamaga H; Wada H; Sugimachi K
Int Surg; 1991; 76(4):214-7. PubMed ID: 1778718
[TBL] [Abstract][Full Text] [Related]
12. Prospective randomized comparison of sodium tetradecyl sulphate & polidocanol for oesophageal variceal sclerotherapy.
Ravi M; Kate V; Ananthakrishnan N
Indian J Med Res; 2001 Jun; 113():228-33. PubMed ID: 11816957
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic sclerotherapy with fibrin glue as compared with polidocanol to prevent early esophageal variceal rebleeding.
Zimmer T; Rucktäschel F; Stölzel U; Liehr RM; Schuppan D; Stallmach A; Zeitz M; Weber E; Riecken EO
J Hepatol; 1998 Feb; 28(2):292-7. PubMed ID: 9514542
[TBL] [Abstract][Full Text] [Related]
14. Prediction of the recurrence of esophageal varices based on portal vein pressure and oxygen tension in portal and peripheral blood.
Obara K; Sakamoto H; Kasukawa R
Gastroenterol Jpn; 1991 Dec; 26(6):707-11. PubMed ID: 1765244
[TBL] [Abstract][Full Text] [Related]
15. A prospective randomized study comparing the effects of large and small volumes of the sclerosant 5% ethanolamine oleate injected into esophageal varices.
Iso Y; Kitano S; Iwanaga T; Koyanagi N; Sugimachi K
Endoscopy; 1988 Nov; 20(6):285-8. PubMed ID: 3229387
[TBL] [Abstract][Full Text] [Related]
16. Ethanolamine oleate versus absolute alcohol as a variceal sclerosant: a prospective, randomized, controlled trial.
Sarin SK; Mishra SP; Sachdev GK; Thorat V; Dalal L; Broor SL
Am J Gastroenterol; 1988 May; 83(5):526-30. PubMed ID: 3284336
[TBL] [Abstract][Full Text] [Related]
17. The value of combined use of N-butyl-2-cyanoacrylate and ethanolamine oleate in the management of bleeding esophagogastric varices.
Thakeb F; Salama Z; Salama H; Abdel Raouf T; Abdel Kader S; Abdel Hamid H
Endoscopy; 1995 Jun; 27(5):358-64. PubMed ID: 7588349
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic sclerotherapy for esophageal varices: a prospective, randomised trial of absolute alcohol versus polidocanol.
Atamkuri SP; Bhargava DK; Sharma MP
Indian J Gastroenterol; 1988 Apr; 7(2):87-9. PubMed ID: 3360476
[No Abstract] [Full Text] [Related]
19. Repeated injection sclerotherapy is preferable to combined therapy with variceal ligation to avoid recurrence of esophageal varices:--a prospective randomized trial.
Iso Y; Kawanaka H; Tomikawa M; Matsumata T; Kitano S; Sugimachi K
Hepatogastroenterology; 1997; 44(14):467-71. PubMed ID: 9164520
[TBL] [Abstract][Full Text] [Related]
20. Trial of sclerosing agents in patients with oesophageal varices.
Kitano S; Iso Y; Yamaga H; Hashizume M; Higashi H; Sugimachi K
Br J Surg; 1988 Aug; 75(8):751-3. PubMed ID: 3048533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
